206 related articles for article (PubMed ID: 32202040)
1. MiR-330-3p contributes to INS-1 cell dysfunction by targeting glucokinase in gestational diabetes mellitus.
Xiao Y; Ding J; Shi Y; Lin L; Huang W; Shen D; Wang W
J Obstet Gynaecol Res; 2020 Jun; 46(6):864-875. PubMed ID: 32202040
[TBL] [Abstract][Full Text] [Related]
2. Role of lncRNA-MEG8/miR-296-3p axis in gestational diabetes mellitus.
Bian G; Xue Y; Liu Y; Xu Y; Chen G; Wu H
Nephrology (Carlton); 2022 Dec; 27(12):994-1002. PubMed ID: 36164928
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-33a-5p sponges to inhibit pancreatic β-cell function in gestational diabetes mellitus LncRNA DANCR.
Feng Y; Qu X; Chen Y; Feng Q; Zhang Y; Hu J; Li X
Reprod Biol Endocrinol; 2020 Jun; 18(1):61. PubMed ID: 32505219
[TBL] [Abstract][Full Text] [Related]
4. miR-520h Inhibits cell survival by targeting mTOR in gestational diabetes mellitus.
Wen J; Bai X
Acta Biochim Pol; 2021 Feb; 68(1):65-70. PubMed ID: 33620957
[TBL] [Abstract][Full Text] [Related]
5. Inhibiting miR-182-3p Alleviates Gestational Diabetes Mellitus by Improving Insulin Resistance in Skeletal Muscle.
Rao J; Chen Y; Huang J; Wu R; Dong Z; Gao Y; Chen X
Balkan Med J; 2022 Mar; 39(2):121-129. PubMed ID: 35330559
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation of microRNA-770-5p influences pancreatic-β-cell function by targeting TP53 regulated inhibitor of apoptosis 1 in gestational diabetes mellitus.
Zhang YL; Chen XQ
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):793-801. PubMed ID: 32016984
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of microRNA-342-3p Eases Insulin Resistance and Liver Gluconeogenesis via Regulating Rfx3 in Gestational Diabetes Mellitus.
Sun Y; Yu Z; Zhang Y; Wang H; Chi Z; Chen X; Xu D
Crit Rev Eukaryot Gene Expr; 2022; 32(6):83-95. PubMed ID: 35997120
[TBL] [Abstract][Full Text] [Related]
8. The 0.1% of the population with glucokinase monogenic diabetes can be recognized by clinical characteristics in pregnancy: the Atlantic Diabetes in Pregnancy cohort.
Chakera AJ; Spyer G; Vincent N; Ellard S; Hattersley AT; Dunne FP
Diabetes Care; 2014; 37(5):1230-6. PubMed ID: 24550216
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol ameliorates the glucose uptake and lipid metabolism in gestational diabetes mellitus mice and insulin-resistant adipocytes via miR-23a-3p/NOV axis.
Zheng T; Chen H
Mol Immunol; 2021 Sep; 137():163-173. PubMed ID: 34256324
[TBL] [Abstract][Full Text] [Related]
10. LncRNA HCG27 Promotes Glucose Uptake Ability of HUVECs by MiR-378a-3p/MAPK1 Pathway.
Zhang JY; Jiang Y; Wei LJ; Zhou X; Zhu SL; Zhang HT; Chen YT; Gao P; Yu J; Wang SS; Feng L
Curr Med Sci; 2023 Aug; 43(4):784-793. PubMed ID: 37405607
[TBL] [Abstract][Full Text] [Related]
11. MiR-34b-3p Impaired HUVECs Viability and Migration via Targeting PDK1 in an In Vitro Model of Gestational Diabetes Mellitus.
Song F; Cai A; Ye Q; Chen X; Lin L; Hao X
Biochem Genet; 2021 Dec; 59(6):1381-1395. PubMed ID: 33856598
[TBL] [Abstract][Full Text] [Related]
12. Role of CircCHD2 in the pathogenesis of gestational diabetes mellitus by regulating autophagy via miR-33b-3p/ULK1 axis.
Bao Y; Wu L; Liu Y; Fan C; Zhang J; Yang J
Placenta; 2024 Jan; 145():27-37. PubMed ID: 38039841
[TBL] [Abstract][Full Text] [Related]
13. MiRNA-221 protects islet β cell function in gestational diabetes mellitus by targeting PAK1.
Zhao H; Tao S
Biochem Biophys Res Commun; 2019 Nov; 520(1):218-224. PubMed ID: 31587871
[TBL] [Abstract][Full Text] [Related]
14. Association of the glucokinase gene promoter polymorphism -30G > A (rs1799884) with gestational diabetes mellitus susceptibility: a case-control study and meta-analysis.
Han X; Cui H; Chen X; Xie W; Chang Y
Arch Gynecol Obstet; 2015 Aug; 292(2):291-8. PubMed ID: 25633883
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA‑143‑3p levels are reduced in the peripheral blood of patients with gestational diabetes mellitus and influences pancreatic β‑cell function and viability.
Liu C; Feng H; Zhang L; Guo Y; Ma J; Yang L
Exp Ther Med; 2023 Feb; 25(2):81. PubMed ID: 36684655
[TBL] [Abstract][Full Text] [Related]
16. Circ-PNPT1 contributes to gestational diabetes mellitus (GDM) by regulating the function of trophoblast cells through miR-889-3p/PAK1 axis.
Zhang L; Zeng M; Tang F; Chen J; Cao D; Tang ZN
Diabetol Metab Syndr; 2021 Jun; 13(1):58. PubMed ID: 34074335
[TBL] [Abstract][Full Text] [Related]
17. Low prevalence of glucokinase gene mutations in gestational diabetic patients with good glycemic control.
Frigeri HR; Santos IC; Réa RR; Almeida AC; Fadel-Picheth CM; Pedrosa FO; Souza EM; Rego FG; Picheth G
Genet Mol Res; 2012 May; 11(2):1433-41. PubMed ID: 22653590
[TBL] [Abstract][Full Text] [Related]
18. miR-134-5p promotes inflammation and apoptosis of trophoblast cells via regulating FOXP2 transcription in gestational diabetes mellitus.
Ke W; Chen Y; Zheng L; Zhang Y; Wu Y; Li L
Bioengineered; 2022 Jan; 13(1):319-330. PubMed ID: 34969354
[TBL] [Abstract][Full Text] [Related]
19. miR-142-3p promotes pancreatic β cell survival through targeting FOXO1 in gestational diabetes mellitus.
Zhang T; Ji C; Shi R
Int J Clin Exp Pathol; 2019; 12(5):1529-1538. PubMed ID: 31933970
[TBL] [Abstract][Full Text] [Related]
20. Association of glucokinase gene and glucokinase regulatory protein gene polymorphisms with gestational diabetes mellitus: A case-control study.
She L; Li W; Guo Y; Zhou J; Liu J; Zheng W; Dai A; Chen X; Wang P; He H; Zhang P; Zeng J; Xiang B; Li S; Wang L; Dai Q; Yang M
Gene; 2022 May; 824():146378. PubMed ID: 35276241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
